World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: IRCT
Last refreshed on: 22 February 2018
Main ID:  IRCT2016050127707N1
Date of registration: 2016-08-16
Prospective Registration: No
Primary sponsor: Shahid Beheshti University of Medical Science-Skin Research Center.
Public title: Efficacy of laser therapy in extrimity wart
Scientific title: Efficacy and safety of nd:yag laser therapy with cryotherapy in extremities(hand,foot) wart
Date of first enrolment: 2016-01-21
Target sample size: 63
Recruitment status: Complete
URL:  http://en.irct.ir/trial/22640
Study type:  interventional
Study design:  Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment.  
Phase:  N/A
Countries of recruitment
Iran (Islamic Republic of)
Contacts
Name: Behzad Iranmanesh   
Address:  The SBMU SRC (Skin Research Center), Shohada-E- Tajrish Educational Hospital, Qods Sq., Tehran, Iran, Islamic Republic Of Tehran Iran (Islamic Republic of)
Telephone: +98 21 2676 1435
Email: behzad_ariiana@yahoo.com mgheisari@sbmu.ac.ir
Affiliation:  Skin Research Center
Name: Dr.Mehdi Gheisari   
Address:  Skin Research Center, Shohada-E- Tajrish Educational Hospital, Qods Sq. ,Tehran, Iran Tehran Tehran Iran (Islamic Republic of)
Telephone: +98 913 151 9705
Email: mgheisari@sbmu.ac.ir
Affiliation:  Skin Research Center
Key inclusion & exclusion criteria
Inclusion criteria: Inclusion criteria:bilateral warts on extremities(upper or lower)

Exclusion criteria:immunodeficiency state(diabetes mellitus;alcohol abuse)
congenital immunodeficiency disorders; hematologic malignancy; drug history of immunnomodulator agent during 4 weeks past;
drug history of anti viral agent during 2 weeks past;pregnancy;breast feeding.

Exclusion criteria:

Age minimum: no limit
Age maximum: no limit
Gender: Both
Health Condition(s) or Problem(s) studied
Anogenital (venereal) warts
wart.
Anogenital (venereal) warts
Intervention(s)
The patients with bilateral extrimitie's warts will join to study,and all of their demoghraphic datas and properties(site,diameter) of warts and association are saved .
after preparation and anesthesia one side treat with long pulsed nd;yag laser(laser optek) with setting , fluence: 200 j/cm^2 , spot size :3mm, duration:20ms? wave length: 1064 nm. in every session with 3 shots circular guide.
all patients follow and evaluate 3 months after the last session, index of treatment is treated lesion devided into tatol lesions.
Intervention 1: The patients with bilateral extrimitie's warts will join to study,and all of their demoghraphic datas and properties(site,diameter) of warts and association are saved .
after preparation and anesthesia one side treat with long pulsed nd;yag laser(laser optek) with setting , fluence: 200 j/cm^2 , spot size :3mm, duration:20ms? wave length: 1064 nm. in every session with 3 shots circular guide.
all patients follow and evaluate 3 months after the last session, index of treatment is treated lesion devided into tatol lesions. Intervention 2: The patients with bilateral extrimitie's warts will join to study,and all of their demoghraphic datas and properties(site,diameter) of warts and association are saved . after preparation and anesthesia one side treat with cryo therapy with liquid nitrogen -196cellsius and 2mm margin with open spray every 2 weeks bye 3 times.
The patients with bilateral extrimitie's warts will join to study,and all of their demoghraphic datas and properties(site,diameter) of warts and association are saved . after preparation and anesthesia one side treat with cryo therapy with liquid nitrogen -196cellsius and 2mm margin with open spray every 2 weeks bye 3 times.
Treatment - Other
Primary Outcome(s)
Diameter of primary lesion on centimeters. Timepoint: 2weeks. Method of measurement: ruller.
Secondary Outcome(s)
Blister and ulser formation. Timepoint: 2 weeks. Method of measurement: physical examination.
Secondary ID(s)
Source(s) of Monetary Support
Shahid Beheshti University of Medical Science-Skin Research Center.
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date:
Contact:
shahid beheshti medical univwersity
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history